{"id":204402,"date":"2026-05-22T06:17:19","date_gmt":"2026-05-22T05:17:19","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/"},"modified":"2026-05-22T06:17:19","modified_gmt":"2026-05-22T05:17:19","slug":"cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/","title":{"rendered":"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1092.jpg\" \/><\/p>\n<p>El Servicio de Medicina Interna del\u00a0<a href=\"https:\/\/www.hospitalsonespases.es\/es\/\" rel=\"noopener\">Hospital Universitario Son Espases<\/a> ha participado en la descripci\u00f3n de los cambios longitudinales en los biomarcadores circulantes desde el inicio del estudio hasta la semana 48 en personas sin tratamiento previo que viven con el VIH y que inician terapia antirretroviral basada en inhibidores de la integrasa.<\/p>","protected":false},"excerpt":{"rendered":"<p>El Servicio de Medicina Interna del\u00a0Hospital Universitario Son Espases ha participado en la descripci\u00f3n de los cambios longitudinales en los biomarcadores circulantes desde el inicio del estudio hasta la semana 48 en personas sin tratamiento previo que viven con el VIH y que inician terapia antirretroviral basada en inhibidores de la integrasa.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-204402","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa\" \/>\n<meta property=\"og:description\" content=\"El Servicio de Medicina Interna del\u00a0Hospital Universitario Son Espases ha participado en la descripci\u00f3n de los cambios longitudinales en los biomarcadores circulantes desde el inicio del estudio hasta la semana 48 en personas sin tratamiento previo que viven con el VIH y que inician terapia antirretroviral basada en inhibidores de la integrasa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-22T05:17:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1092.jpg\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa\",\"datePublished\":\"2026-05-22T05:17:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/\"},\"wordCount\":71,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1092.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/\",\"name\":\"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1092.jpg\",\"datePublished\":\"2026-05-22T05:17:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1092.jpg\",\"contentUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1092.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/","og_locale":"es_ES","og_type":"article","og_title":"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa","og_description":"El Servicio de Medicina Interna del\u00a0Hospital Universitario Son Espases ha participado en la descripci\u00f3n de los cambios longitudinales en los biomarcadores circulantes desde el inicio del estudio hasta la semana 48 en personas sin tratamiento previo que viven con el VIH y que inician terapia antirretroviral basada en inhibidores de la integrasa.","og_url":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/","og_site_name":"bip4ex","article_published_time":"2026-05-22T05:17:19+00:00","og_image":[{"url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1092.jpg","type":"","width":"","height":""}],"author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa","datePublished":"2026-05-22T05:17:19+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/"},"wordCount":71,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1092.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/","url":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/","name":"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/#primaryimage"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1092.jpg","datePublished":"2026-05-22T05:17:19+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/#primaryimage","url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1092.jpg","contentUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1092.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/cambios-en-biomarcadores-hasta-la-semana-48-en-personas-con-vih-que-inician-terapia-con-inhibidores-de-la-integrasa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Cambios en biomarcadores hasta la semana 48 en personas con VIH que inician terapia con inhibidores de la integrasa"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/204402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=204402"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/204402\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=204402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=204402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=204402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}